U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C79H117N7O56S7.8Na
Molecular Weight 2469.161
Optical Activity UNSPECIFIED
Defined Stereocenters 27 / 27
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EP-42675

SMILES

[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[H][C@]5(O[C@H]1[C@H](OC)[C@@H](OC)[C@]([H])(O[C@@H]2[C@@H](COS([O-])(=O)=O)O[C@H](O[C@@]3([H])[C@H](OC)[C@@H](OC)[C@H](O[C@]4([H])[C@@H](COS([O-])(=O)=O)O[C@H](OC)[C@H](OS([O-])(=O)=O)[C@H]4OC)O[C@H]3C([O-])=O)[C@H](OS([O-])(=O)=O)[C@H]2OS([O-])(=O)=O)O[C@@H]1C([O-])=O)O[C@H](COS([O-])(=O)=O)[C@@H](OCCOCCOCCOCCNC(=O)CCCNC(=O)C[C@H](NS(=O)(=O)C6=C(C)C(C)=C(OC)C=C6C)C(=O)N[C@H](CC7=CC=C(C=C7)C(N)=N)C(=O)N8CCCCC8)[C@H](OC)[C@H]5OC

InChI

InChIKey=DFRCPVPOZMLZGH-KIDSDGJESA-F
InChI=1S/C79H125N7O56S7.8Na/c1-39-33-46(115-4)40(2)41(3)69(39)143(95,96)85-44(71(89)84-45(72(90)86-24-14-13-15-25-86)34-42-18-20-43(21-19-42)70(80)81)35-51(88)82-22-16-17-50(87)83-23-26-124-27-28-125-29-30-126-31-32-127-52-47(36-128-144(97,98)99)132-76(64(120-9)55(52)116-5)136-59-57(118-7)66(122-11)78(139-62(59)73(91)92)135-54-49(38-130-146(103,104)105)133-79(68(142-149(112,113)114)61(54)140-147(106,107)108)137-60-58(119-8)65(121-10)77(138-63(60)74(93)94)134-53-48(37-129-145(100,101)102)131-75(123-12)67(56(53)117-6)141-148(109,110)111;;;;;;;;/h18-21,33,44-45,47-49,52-68,75-79,85H,13-17,22-32,34-38H2,1-12H3,(H3,80,81)(H,82,88)(H,83,87)(H,84,89)(H,91,92)(H,93,94)(H,97,98,99)(H,100,101,102)(H,103,104,105)(H,106,107,108)(H,109,110,111)(H,112,113,114);;;;;;;;/q;8*+1/p-8/t44-,45+,47+,48+,49+,52+,53+,54+,55-,56-,57-,58-,59-,60-,61-,62-,63+,64+,65+,66+,67+,68+,75-,76+,77+,78+,79+;;;;;;;;/m0......../s1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C79H117N7O56S7
Molecular Weight 2285.243
Charge -8
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 27 / 27
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 12:02:16 GMT 2023
Edited
by admin
on Sat Dec 16 12:02:16 GMT 2023
Record UNII
DUM42I2BVP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EP-42675
Code English
(2S,3S,4S,5R,6R)-3-((2R,3R,4S,5R,6R)-5-(2-(2-(2-(2-(4-(((3S)-4-(((1R)-1-((4-CARBAMIMIDOYLPHENYL)METHYL)-2-OXO-2-(1-PIPERIDYL)ETHYL)AMINO)-3-((4-METHOXY-2,3,6-TRIMETHYL-PHENYL)SULFONYLAMINO)-4-OXO-BUTANOYL)AMINO)BUTANOYLAMINO)ETHOXY)ETHOXY)ETHOXY)ETHOXY)-
Systematic Name English
ORG-42675
Code English
.ALPHA.-D-GLUCOPYRANOSIDE, METHYL O-4-O-((20S,23R)-23-((4-(AMINOIMINOMETHYL)PHENYL)METHYL)-20-(((4-METHOXY-2,3,6-TRIMETHYLPHENYL)SULFONYL)AMINO)-13,18,21,24-TETRAOXO-24-(1-PIPERIDINYL)-3,6,9-TRIOXA-12,17,22-TRIAZATETRACOS-1-YL)-2,3-DI-O-METHYL-6-O-SULFO-
Systematic Name English
Code System Code Type Description
FDA UNII
DUM42I2BVP
Created by admin on Sat Dec 16 12:02:16 GMT 2023 , Edited by admin on Sat Dec 16 12:02:16 GMT 2023
PRIMARY
PUBCHEM
11600660
Created by admin on Sat Dec 16 12:02:16 GMT 2023 , Edited by admin on Sat Dec 16 12:02:16 GMT 2023
PRIMARY
CAS
343776-67-0
Created by admin on Sat Dec 16 12:02:16 GMT 2023 , Edited by admin on Sat Dec 16 12:02:16 GMT 2023
PRIMARY
SMS_ID
300000043979
Created by admin on Sat Dec 16 12:02:16 GMT 2023 , Edited by admin on Sat Dec 16 12:02:16 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
ORG-42675
Created by admin on Sat Dec 16 12:02:16 GMT 2023 , Edited by admin on Sat Dec 16 12:02:16 GMT 2023
PRIMARY Org 42675 [343776-67-0]
Related Record Type Details
ACTIVE MOIETY
This compound (Org 42675) has a 10 times longer half-life compared with the original half-life of the direct thrombin inhibitor, while the thrombin inhibitory activity is maintained. An extra advantage of this product is the inhibitory activity on thrombin generation via antithrombin III (AT)-mediated factor (F)Xa inhibition. Finally, Org 42675 was far more active than the three reference compounds in an experimental thrombolysis model in rabbits.
ACTIVE MOIETY
EP42675 was well tolerated in 100 healthy subjects enrolled in five phase I, including single-dose and multiple ascending dose studies and a pharmacodynamic interaction study with a combination of oral aspirin and clopidogrel. The only drug-related adverse effects were minor episodes of bleedings (mostly at the injection or blood sampling site) explained by the anticoagulant activity of EP42675. Vital signs, physical examination, ECG (including the QTc interval) and safety laboratory parameters did not show any treatment-emergent clinically relevant abnormalities.